Brian Weinstein
Stock Analyst at William Blair
(0.43)
# 3,922
Out of 4,820 analysts
9
Total ratings
33.33%
Success rate
-19.18%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Brian Weinstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TXG 10x Genomics | Downgrades: Market Perform | n/a | $8.30 | - | 2 | Jul 15, 2022 | |
| GKOS Glaukos | Upgrades: Outperform | n/a | $96.68 | - | 3 | Feb 3, 2022 | |
| SERA Sera Prognostics | Initiates: Outperform | n/a | $3.15 | - | 1 | Aug 9, 2021 | |
| BDSX Biodesix | Initiates: Outperform | n/a | $0.54 | - | 1 | Nov 23, 2020 | |
| QDEL QuidelOrtho | Upgrades: Outperform | n/a | $28.09 | - | 2 | Jul 18, 2017 |
10x Genomics
Jul 15, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $8.30
Upside: -
Glaukos
Feb 3, 2022
Upgrades: Outperform
Price Target: n/a
Current: $96.68
Upside: -
Sera Prognostics
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.15
Upside: -
Biodesix
Nov 23, 2020
Initiates: Outperform
Price Target: n/a
Current: $0.54
Upside: -
QuidelOrtho
Jul 18, 2017
Upgrades: Outperform
Price Target: n/a
Current: $28.09
Upside: -